Ensayos clínicos

Inclusion Criteria

• Female
• ≥ 18 years of age
• Group 1
  • All  consented under IRB 1815-04 and agreed to the cardiac portion
  • Have data that includes information such as echocardiograms (pre-treatment, during treatment and at end of treatment), endoPATs, and bloods collected as part of the cardiac study under this IRB
  • Letter of support obtained from Dr. Olson for this information
• Group 2
  • Newly diagnosed with HER-2 positive breast cancer
  • Seen at Mayo Clinic Rochester
  • Is planning to undergo anti-HER2 therapy with or without anthracycline within the Mayo Clinic Health System
    • May have treatment at an outside facility if they are willing to return to Mayo Clinic for their cardiac monitoring
  • Meet our inclusion criteria

Exclusion Criteria 

• Left ventricular ejection fraction < 50%